Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Descartes-08 for Patients With Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Descartes-08 is being tested in a Phase 2 trial for systemic lupus erythematosus, and the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Descartes-08

Snippet

Sponsor: Cartesian Therapeutics | Conditions: Systemic Lupus Erythematosus (SLE) | Phase 2 | Status: ACTIVE_NOT_RECRUITING